Indication
Galliprant controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information
For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting
NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring
are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be
avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in
dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should
be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and
decreases in serum albumin and total protein. Click here for full prescribing information
Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. ©2026 Elanco or its affiliates. PM-US-26-0053(2)
CANINE OA HEATING UP?
Prescribe Galliprant
®
(grapiprant tablets) when your
canine patients present with osteoarthritis. Galliprant
doesn't just fight OA pain—it reduces OA inflammation.
• Targeted relief for canine OA pain and inflammation
• Easy to administer a once-daily dose that can be
given by the pet owner without injections
• First-in-class non-COX inhibiting NSAID with a
targeted mode of action
Buy Now: Covetrus.vet/Galliprant
Gallipr
ant
For oral
use
in
dane
EP4
Prostaglandin
Receptor
Antagonist
NSAID
Caution: Federal law restricts
this
drug
to
use
by
or
on
the order of
licensed
veterinarian.
90
FLAVORED
TABLETS
in
dogs
only
